当前位置:首页 - 行情中心 - 国药现代(600420) - 财务分析 - 现金流量表

国药现代

(600420)

  

流通市值:170.06亿  总市值:170.06亿
流通股本:13.41亿   总股本:13.41亿

现金流量表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金8,063,674,065.435,541,758,391.532,927,957,863.311,311,900,526.79
收到的税费返还31,042,213.9219,953,600.9510,883,051.9175,847,533.17
收到其他与经营活动有关的现金414,634,771.67890,163,266.77201,072,402.94605,954,113.04
经营活动现金流入的平衡项目0000
经营活动现金流入小计8,509,351,051.026,451,875,259.253,139,913,318.1511,993,702,173
购买商品、接受劳务支付的现金3,392,793,453.042,318,605,934.781,172,877,325.064,374,052,674.49
支付给职工以及为职工支付的现金1,299,639,115.27887,424,939.91510,641,763.51,633,129,543.31
支付的各项税费591,153,950.53455,512,208.09239,882,899.73827,480,346.36
支付其他与经营活动有关的现金1,199,304,587.55973,324,777.25505,106,422.313,438,665,820.8
经营活动现金流出的平衡项目0000
经营活动现金流出小计6,482,891,106.394,634,867,860.032,428,508,410.610,273,328,384.96
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额2,026,459,944.631,817,007,399.22711,404,907.551,720,373,788.04
二、投资活动产生的现金流量:
收回投资收到的现金2,286,637.19--2,007,363.27
取得投资收益收到的现金6,881,470.82--26,191,023.72
处置固定资产、无形资产和其他长期资产收回的现金净额14,728,000.481,196,950.28811,982.2810,958,823.72
收到的其他与投资活动有关的现金677,573,861.16---
投资活动现金流入的平衡项目0000
投资活动现金流入小计701,469,969.651,196,950.28811,982.2839,157,210.71
购建固定资产、无形资产和其他长期资产支付的现金156,028,789.97110,215,678.2856,070,994.8357,193,792.2
支付其他与投资活动有关的现金1,900,000,000497,000,000130,000,0001,044,850,916.67
投资活动现金流出的平衡项目0000
投资活动现金流出小计2,056,028,789.97607,215,678.28186,070,994.81,402,044,708.87
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-1,354,558,820.32-606,018,728-185,259,012.52-1,362,887,498.16
三、筹资活动产生的现金流量:
取得借款收到的现金50,000,00020,000,000-45,000,000
筹资活动现金流入平衡项目00-0
筹资活动现金流入小计50,000,00020,000,000-45,000,000
偿还债务支付的现金45,000,00025,000,000-752,800,000
分配股利、利润或偿付利息支付的现金379,369,643.21172,797,716.6936,101,474.56364,159,004.86
其中:子公司支付给少数股东的股利、利润81,037,635.296,951,628.164,500,000174,804,142.71
支付其他与筹资活动有关的现金32,695,096.0711,920,872.98,911,256.8221,431,162.45
筹资活动现金流出平衡项目0000
筹资活动现金流出小计457,064,739.28209,718,589.5945,012,731.381,138,390,167.31
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-407,064,739.28-189,718,589.59-45,012,731.38-1,093,390,167.31
四、汇率变动对现金及现金等价物的影响24,552,595.3418,510,922.582,498,251.0332,072,779.71
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额289,388,980.371,039,781,004.21483,631,414.68-703,831,097.72
加:期初现金及现金等价物余额5,131,044,857.85,131,044,857.85,134,331,493.775,834,875,955.52
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额5,420,433,838.176,170,825,862.015,617,962,908.455,131,044,857.8
补充资料:
净利润-886,887,725.63-964,610,734.18
资产减值准备-11,308,517.94-61,050,750.61
固定资产和投资性房地产折旧-360,850,118.54-767,193,287.58
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-360,850,118.54-767,193,287.58
无形资产摊销-20,531,958.47-37,290,253.94
长期待摊费用摊销-3,708,034-6,359,327.52
处置固定资产、无形资产和其他长期资产的损失-2,049,581.83-31,845,024.31
固定资产报废损失-566,673.5-2,560,421.78
财务费用-18,697,936.94-57,883,690.44
投资损失--16,838,682.09--27,453,725.69
递延所得税-61,925,459.78--11,446,123.97
其中:递延所得税资产减少-7,073,396.21--10,297,847.97
递延所得税负债增加-54,852,063.57--1,148,276
存货的减少--5,360,046.11-163,267,685.67
经营性应收项目的减少-240,245,336.14-485,426,559.99
经营性应付项目的增加-221,636,177.3--832,616,234.65
现金的期末余额-6,170,825,862.01-5,131,044,857.8
减:现金的期初余额-5,131,044,857.8-5,834,875,955.52
公告日期2024-10-292024-08-282024-04-302024-03-30
审计意见(境内)标准无保留意见
TOP↑